Literature DB >> 23291635

Hepatocyte nuclear factor 6 activates the transcription of CYP3A4 in hepatocyte-like cells differentiated from human induced pluripotent stem cells.

Takamitsu Sasaki1, Shogo Takahashi, Yoshihiro Numata, Masayo Narita, Yutaka Tanaka, Takeshi Kumagai, Yuki Kondo, Tamihide Matsunaga, Shigeru Ohmori, Kiyoshi Nagata.   

Abstract

Human induced pluripotent stem cells (iPSCs) are a valuable source of hepatocytes for applications in drug metabolism studies. However, the current protocols for generating iPSC-derived hepatocyte-like cells (iPSHCs) are still very inefficient, and iPSHCs do not have sufficient hepatocyte-specific features, which include expression of a series of hepatocyte-specific genes, such as those encoding cytochrome P450 (CYP). In this study, we investigated whether introduction of human hepatocyte nuclear factor 6 (HNF6) could modulate the expression of CYP3A4 and other CYP genes in iPSHCs as well as in HepG2 cells, a fetal liver cell line (HFL cells), and in hepatocytes. CYP3A4 mRNA could be detected in iPSHCs, but the expression level was very low compared with those in HepG2 cells and hepatocytes. However, the CYP3A4 mRNA levels markedly increased on introduction of HNF6 and reached one-tenth of those in hepatocytes. We also found that HNF6 introduction increased CYP3A4 gene transcription in HFL cells and HepG2 cells, which have features similar to those of fetal hepatocyte-like cells; however, it did not affect CYP3A4 mRNA expression in hepatocytes. These results suggest that HNF6 plays an important role in the gene regulation of CYP3A4 during development from the fetal period to the postnatal period.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23291635     DOI: 10.2133/dmpk.dmpk-12-rg-132

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  4 in total

1.  Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.

Authors:  Huaqiang Zhu; Yuetang Mi; Xian Jiang; Xu Zhou; Rui Li; Zheng Wei; Hongchi Jiang; Jun Lu; Xueying Sun
Journal:  J Cancer Res Clin Oncol       Date:  2016-01-29       Impact factor: 4.553

2.  Differentiation of human-induced pluripotent stem cell under flow conditions to mature hepatocytes for liver tissue engineering.

Authors:  Viktoriia Starokozhko; Mette Hemmingsen; Layla Larsen; Soumyaranjan Mohanty; Marjolijn Merema; Rodrigo C Pimentel; Anders Wolff; Jenny Emnéus; Anders Aspegren; Geny Groothuis; Martin Dufva
Journal:  J Tissue Eng Regen Med       Date:  2018-04-06       Impact factor: 3.963

3.  A comparison of hepato-cellular in vitro platforms to study CYP3A4 induction.

Authors:  Beyza Bulutoglu; Camilo Rey-Bedón; Safak Mert; Lipeng Tian; Yoon-Young Jang; Martin L Yarmush; O Berk Usta
Journal:  PLoS One       Date:  2020-02-27       Impact factor: 3.240

Review 4.  Two Effective Routes for Removing Lineage Restriction Roadblocks: From Somatic Cells to Hepatocytes.

Authors:  Chenxia Hu; Lanjuan Li
Journal:  Int J Mol Sci       Date:  2015-09-01       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.